This ticker will go up because of this, imo:
Last year all I heard about was the "Going concern" and "won't have enough money to operate for 30 days much less 3 month" and yet here we are a year later with way more than one Dr on board and enthusiastic.
Last year the possibility of going international helped shoot this to .05 PPS and higher without ANY actual foreign doctor on board... but we now have an enthusiastic (and publishing favorable articles) Dr on board from Italy.
CELZ is a paradigm changing company because they don't manufacture needles, centrifuges, or any other pill or device for CaverStem and FemCelz… The company literally profits off of its IP alone after some training. We don't employ piles of doctors and their staff, nor do we require the $250,000 or higher new clinic startup costs.
Unlike ANY other product out there for the same stem cell treatment for ED, our IP product is FDA compliant and protected by trademark and patent(s).
Of course the Q1 revenues will be higher year over year when released today. We get clinic expansion and additional doctors paying us without the huge overhead! Naturally Bloomberg wanted their name on our company Press Release. While failure is always an orphan, success has MANY fathers and Bloomberg will likely run articles in the future as well. After all an Italian Doctor got quoted referring to our IP product as a "Bombshell" improvement over other treatments for his 60+ patients treated to date.
All in my opinion, of course, but I for one am REALLLLY glad I am in the milly share club here and I'll wait as long as it takes for PPS to catch up to where we should be... Things are so clear here that even I can see them.... Whassup?
-Go CELZ$$$
All imho offered freely. Understand you should not take my advice in lieu of doing your own work to invest suitable to you. The cape doesn't give me super powers IRL.
